A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. OH&RM [Internet]. 2023 Sep. 29 [cited 2026 Jul. 11];4(4):19-26. Available from: https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/374